New mutations conferring resistance to SARS-CoV-2 therapeutics have important clinical
implications. We describe the first cases of an independently acquired V792I RNA-dependent …

The efficacy of COVID-19 mRNA vaccines is high, but breakthrough infections still occur. We
compared the SARS-CoV-2 genomes of 76 breakthrough cases after full vaccination with …

Effective public response to a pandemic relies upon accurate measurement of the extent and
dynamics of an outbreak. Viral genome sequencing has emerged as a powerful approach …

Background High rates of vaccination and natural infection drive immunity and redirect selective
viral adaptation. Updated boosters are installed to cope with drifted viruses, yet data on …

Cytoplasmic long non-coding RNAs have been shown to act at many different levels to control
post-transcriptional gene expression, although their role in translational control is poorly …

Since the latter part of 2020, SARS-CoV-2 evolution has been characterised by the
emergence of viral variants associated with distinct biological characteristics. While the main …

The emergence of recombinant viruses is a threat to public health, as recombination may
integrate variant-specific features that together result in escape from treatment or immunity. The …

Guanine‐quadruplexes (G4) included in RNA molecules exert several functions in controlling
gene expression at post‐transcriptional level; however, the molecular mechanisms of G4‐…

One of the main challenges in the fight against coronavirus disease 2019 (COVID-19) stems
from the ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

Of 379 severe acute respiratory syndrome coronavirus 2 samples collected in New York,
USA, we detected 86 Omicron variant sequences containing Delta variant mutation P681R. …